menu
    • menu

    Company profile for Everads Therapy

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Everads Therapy is an early-stage life sciences company developing the next generation of retinal treatment delivery technologies. With the goal of overcoming significant challenges in current treatment methodologies for retinal and macular diseases, Everads' delivery system offers the promise of improving the efficacy and safety of existing and potential drug therapies. Established in 2017, Everads Therapy operates within the...
    Everads Therapy is an early-stage life sciences company developing the next generation of retinal treatment delivery technologies. With the goal of overcoming significant challenges in current treatment methodologies for retinal and macular diseases, Everads' delivery system offers the promise of improving the efficacy and safety of existing and potential drug therapies. Established in 2017, Everads Therapy operates within the RAD Biomed incubator in Tel Aviv, Israel. Its underlying technologies have been licensed from the Sheba Medical Center at Tel Hashomer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Everads TherapyIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Migdalei Orr,. Building A 27 Habarzel st. 5ft floor, Migdaly Or, Building A, i...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.everads-therapy.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/everads-therapy/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Everads to Present Trial Results at ASRS 2025 with New Injector
    Everads to Present Trial Results at ASRS 2025 with New Injector

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everads-announces-two-oral-presentations-at-asrs-2025-including-full-clinical-trial-results-with-its-novel-suprachoroidal-injector-302517682.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    Everads to Present Five Abstracts at ARVO 2025
    Everads to Present Five Abstracts at ARVO 2025

    01 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everads-announces-five-abstracts-accepted-for-presentation-at-arvo-2025-including-first-in-human-results-using-its-novel-suprachoroidal-injector-302444028.html

    PR NEWSWIRE
    01 May 2025
    Share Share
    Everads Enters Agreement with Kriya for Development of Ocular Gene Therapy
    Everads Enters Agreement with Kriya for Development of Ocular Gene Therapy

    27 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everads-enters-license-agreement-with-kriya-for-development-of-ocular-gene-therapy-candidates-using-everads-suprachoroidal-delivery-technology-301940335.html

    PR NEWSWIRE
    27 Sep 2023
    Share Share
    VivaVision and Everads Collaborate to Develop Durable and Effective Therapies
    VivaVision and Everads Collaborate to Develop Durable and Effective Therapies

    06 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vivavision-and-everads-collaborate-to-develop-durable-and-effective-therapies-for-retinal-diseases-301715314.html

    PR NEWSWIRE
    06 Jan 2023
    Share Share
    Everads Ink Collaboration to Evaluate its Suprachoroidal Delivery Technology
    Everads Ink Collaboration to Evaluate its Suprachoroidal Delivery Technology

    30 Jun 2021

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everads-enters-into-collaboration-to-evaluate-its-suprachoroidal-delivery-technology-with-a-clinical-stage-gene-therapy-company-301323334.html

    PR NEWSWIRE
    30 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search